The presence of V600E BRAF mutations observed in 5.1% of metastatic CRC patients, but not non-V600E BRAF mutations was associated with worse prognosis (reduced survival and frequent and rapid recurrence) after resection of CLMs [58]. The gene discussed is BRAF; the disease is colorectal carcinoma.